FDA — authorised 21 November 1969
- Application: NDA016807
- Marketing authorisation holder: ALLERGAN
- Local brand name: THYROLAR-5
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 EUTHROID-2 in United States
FDA authorised EUTHROID-2 on 21 November 1969
Marketing authorisations
FDA
- Status: approved
FDA
- Application: NDA016680
- Marketing authorisation holder: PARKE DAVIS
- Local brand name: EUTHROID-1
- Indication: TABLET — ORAL
- Status: approved
EUTHROID-2 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is EUTHROID-2 approved in United States?
Yes. FDA authorised it on 21 November 1969; FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for EUTHROID-2 in United States?
ALLERGAN holds the US marketing authorisation.